Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to improve patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors.
The two organizations have signed an agreement that aims to improve care for patients with these conditions and expand access to new imaging and interventional technologies.
Some initial areas for collaboration include the following:
- Advancement and clinical translation of AI-enabled MRI protocols for improved diagnostic accuracy and patient monitoring for neurodegenerative diseases.
- Minimally invasive, image-guided interventional suites for the precise detection and treatment of liver metastases.
- An ultrahigh-field MRI innovation center for diagnostic and surgical planning in complex neurological disease states.
- A whole body PET/CT and PET/MR innovation center, emphasizing theranostics treatment for certain cancers and simultaneous anatomical and metabolic MR imaging for precise diagnostic and therapeutic planning.
